Reply to: "Adjuvant Medications that Improve Survival after Locoregional Therapy"
J Vasc Interv Radiol
.
2017 Sep;28(9):1335-1336.
doi: 10.1016/j.jvir.2017.06.028.
Authors
F Edward Boas
1
,
Etay Ziv
1
,
Hooman Yarmohammadi
1
,
Karen T Brown
1
,
Joseph P Erinjeri
1
,
Constantinos T Sofocleous
1
,
James J Harding
2
,
Stephen B Solomon
1
Affiliations
1
Interventional Radiology Service, Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10065.
2
Gastrointestinal Medical Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10065.
PMID:
28841960
PMCID:
PMC6636677
DOI:
10.1016/j.jvir.2017.06.028
No abstract available
Publication types
Letter
Comment
MeSH terms
Chemotherapy, Adjuvant*
Humans
Liver Neoplasms / therapy*
Radiotherapy, Adjuvant*
Grants and funding
P30 CA008748/CA/NCI NIH HHS/United States